Schwarzschild MA - Search Results

1

Targeting urate to reduce oxidative stress in Parkinson disease.

Crotty GF, Ascherio A, Schwarzschild MA. Crotty GF, et al. Among authors: schwarzschild ma. Exp Neurol. 2017 Dec;298(Pt B):210-224. doi: 10.1016/j.expneurol.2017.06.017. Epub 2017 Jun 13. Exp Neurol. 2017. PMID: 28622913 Free PMC article. Review.

2

Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

Schwarzschild MA, Chen JF, Ascherio A. Schwarzschild MA, et al. Neurology. 2002 Apr 23;58(8):1154-60. doi: 10.1212/wnl.58.8.1154. Neurology. 2002. PMID: 11971080 Review.

3

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease.

Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE. Ascherio A, et al. Among authors: schwarzschild ma. Neurology. 2003 Mar 11;60(5):790-5. doi: 10.1212/01.wnl.0000046523.05125.87. Neurology. 2003. PMID: 12629235

4

Prospective study of phobic anxiety and risk of Parkinson's disease.

Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Weisskopf MG, et al. Among authors: schwarzschild ma. Mov Disord. 2003 Jun;18(6):646-51. doi: 10.1002/mds.10425. Mov Disord. 2003. PMID: 12784267

5

Alcohol consumption and the incidence of Parkinson's disease.

Hernán MA, Chen H, Schwarzschild MA, Ascherio A. Hernán MA, et al. Among authors: schwarzschild ma. Ann Neurol. 2003 Aug;54(2):170-5. doi: 10.1002/ana.10611. Ann Neurol. 2003. PMID: 12891669

6

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Chen H, Zhang SM, Hernán MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A. Chen H, et al. Among authors: schwarzschild ma. Arch Neurol. 2003 Aug;60(8):1059-64. doi: 10.1001/archneur.60.8.1059. Arch Neurol. 2003. PMID: 12925360

7

Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease.

Schwarzschild MA, Xu K, Oztas E, Petzer JP, Castagnoli K, Castagnoli N Jr, Chen JF. Schwarzschild MA, et al. Neurology. 2003 Dec 9;61(11 Suppl 6):S55-61. doi: 10.1212/01.wnl.0000095214.53646.72. Neurology. 2003. PMID: 14663012 Review.

8

Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease.

Chen JF, Fredduzzi S, Bastia E, Yu L, Moratalla R, Ongini E, Schwarzschild MA. Chen JF, et al. Among authors: schwarzschild ma. Neurology. 2003 Dec 9;61(11 Suppl 6):S74-81. doi: 10.1212/01.wnl.0000095218.26363.7b. Neurology. 2003. PMID: 14663016

9

Obesity and the risk of Parkinson's disease.

Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Willett WC, Ascherio A. Chen H, et al. Among authors: schwarzschild ma. Am J Epidemiol. 2004 Mar 15;159(6):547-55. doi: 10.1093/aje/kwh059. Am J Epidemiol. 2004. PMID: 15003958

10

Folate intake and risk of Parkinson's disease.

Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Logroscino G, Willett WC, Ascherio A. Chen H, et al. Among authors: schwarzschild ma. Am J Epidemiol. 2004 Aug 15;160(4):368-75. doi: 10.1093/aje/kwh213. Am J Epidemiol. 2004. PMID: 15286022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters